Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global and Japan Diabetic Retinopathy (DR) Analysis Software Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Diabetic Retinopathy (DR) Analysis Software Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 AI Screening System
    • 1.2.3 AI Analysis (Disease Assessment)
  • 1.3 Market by Application
    • 1.3.1 Global Diabetic Retinopathy (DR) Analysis Software Market Share by Application: 2020 VS 2026
    • 1.3.2 Clinical Diagnoses
    • 1.3.3 Personal Triage
    • 1.3.4 Investigational Use
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Diabetic Retinopathy (DR) Analysis Software Market Perspective (2015-2026)
  • 2.2 Global Diabetic Retinopathy (DR) Analysis Software Growth Trends by Regions
    • 2.2.1 Diabetic Retinopathy (DR) Analysis Software Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Diabetic Retinopathy (DR) Analysis Software Historic Market Share by Regions (2015-2020)
    • 2.2.3 Diabetic Retinopathy (DR) Analysis Software Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Diabetic Retinopathy (DR) Analysis Software Players by Market Size
    • 3.1.1 Global Top Diabetic Retinopathy (DR) Analysis Software Players by Revenue (2015-2020)
    • 3.1.2 Global Diabetic Retinopathy (DR) Analysis Software Revenue Market Share by Players (2015-2020)
  • 3.2 Global Diabetic Retinopathy (DR) Analysis Software Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Diabetic Retinopathy (DR) Analysis Software Revenue
  • 3.4 Global Diabetic Retinopathy (DR) Analysis Software Market Concentration Ratio
    • 3.4.1 Global Diabetic Retinopathy (DR) Analysis Software Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Diabetic Retinopathy (DR) Analysis Software Revenue in 2019
  • 3.5 Key Players Diabetic Retinopathy (DR) Analysis Software Area Served
  • 3.6 Key Players Diabetic Retinopathy (DR) Analysis Software Product Solution and Service
  • 3.7 Date of Enter into Diabetic Retinopathy (DR) Analysis Software Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetic Retinopathy (DR) Analysis Software Breakdown Data by Type (2015-2026)

  • 4.1 Global Diabetic Retinopathy (DR) Analysis Software Historic Market Size by Type (2015-2020)
  • 4.2 Global Diabetic Retinopathy (DR) Analysis Software Forecasted Market Size by Type (2021-2026)

5 Diabetic Retinopathy (DR) Analysis Software Breakdown Data by Application (2015-2026)

  • 5.1 Global Diabetic Retinopathy (DR) Analysis Software Historic Market Size by Application (2015-2020)
  • 5.2 Global Diabetic Retinopathy (DR) Analysis Software Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Diabetic Retinopathy (DR) Analysis Software Market Size (2015-2026)
  • 6.2 North America Diabetic Retinopathy (DR) Analysis Software Market Size by Type (2015-2020)
  • 6.3 North America Diabetic Retinopathy (DR) Analysis Software Market Size by Application (2015-2020)
  • 6.4 North America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Diabetic Retinopathy (DR) Analysis Software Market Size (2015-2026)
  • 7.2 Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Type (2015-2020)
  • 7.3 Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Application (2015-2020)
  • 7.4 Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Diabetic Retinopathy (DR) Analysis Software Market Size (2015-2026)
  • 8.2 China Diabetic Retinopathy (DR) Analysis Software Market Size by Type (2015-2020)
  • 8.3 China Diabetic Retinopathy (DR) Analysis Software Market Size by Application (2015-2020)
  • 8.4 China Diabetic Retinopathy (DR) Analysis Software Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Diabetic Retinopathy (DR) Analysis Software Market Size (2015-2026)
  • 9.2 Japan Diabetic Retinopathy (DR) Analysis Software Market Size by Type (2015-2020)
  • 9.3 Japan Diabetic Retinopathy (DR) Analysis Software Market Size by Application (2015-2020)
  • 9.4 Japan Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Diabetic Retinopathy (DR) Analysis Software Market Size (2015-2026)
  • 10.2 Southeast Asia Diabetic Retinopathy (DR) Analysis Software Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Diabetic Retinopathy (DR) Analysis Software Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Evolucare
    • 11.1.1 Evolucare Company Details
    • 11.1.2 Evolucare Business Overview
    • 11.1.3 Evolucare Diabetic Retinopathy (DR) Analysis Software Introduction
    • 11.1.4 Evolucare Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2015-2020))
    • 11.1.5 Evolucare Recent Development
  • 11.2 IDx Technologies Inc.
    • 11.2.1 IDx Technologies Inc. Company Details
    • 11.2.2 IDx Technologies Inc. Business Overview
    • 11.2.3 IDx Technologies Inc. Diabetic Retinopathy (DR) Analysis Software Introduction
    • 11.2.4 IDx Technologies Inc. Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2015-2020)
    • 11.2.5 IDx Technologies Inc. Recent Development
  • 11.3 Yingtong
    • 11.3.1 Yingtong Company Details
    • 11.3.2 Yingtong Business Overview
    • 11.3.3 Yingtong Diabetic Retinopathy (DR) Analysis Software Introduction
    • 11.3.4 Yingtong Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2015-2020)
    • 11.3.5 Yingtong Recent Development
  • 11.4 Vistel
    • 11.4.1 Vistel Company Details
    • 11.4.2 Vistel Business Overview
    • 11.4.3 Vistel Diabetic Retinopathy (DR) Analysis Software Introduction
    • 11.4.4 Vistel Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2015-2020)
    • 11.4.5 Vistel Recent Development
  • 11.5 MONA
    • 11.5.1 MONA Company Details
    • 11.5.2 MONA Business Overview
    • 11.5.3 MONA Diabetic Retinopathy (DR) Analysis Software Introduction
    • 11.5.4 MONA Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2015-2020)
    • 11.5.5 MONA Recent Development
  • 11.6 Eyenuk
    • 11.6.1 Eyenuk Company Details
    • 11.6.2 Eyenuk Business Overview
    • 11.6.3 Eyenuk Diabetic Retinopathy (DR) Analysis Software Introduction
    • 11.6.4 Eyenuk Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2015-2020)
    • 11.6.5 Eyenuk Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    The software is artificial intelligence-based, composed of automated DR screening and mobile or hardware components. The goal is to bring long term and cheap diabetic retinopathy screening to diabetic patients through ML or mobile phones. The core technique for the analysis is deep learning module, and with the web interfaces, both doctors and patients could visually understand the results.
    Market Analysis and Insights: Global Diabetic Retinopathy (DR) Analysis Software Market
    The global Diabetic Retinopathy (DR) Analysis Software market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
    With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetic Retinopathy (DR) Analysis Software market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetic Retinopathy (DR) Analysis Software market in terms of revenue.
    On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetic Retinopathy (DR) Analysis Software market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetic Retinopathy (DR) Analysis Software market.
    Diabetic Retinopathy (DR) Analysis Software Breakdown Data by Type
    AI Screening System
    AI Analysis (Disease Assessment)
    Diabetic Retinopathy (DR) Analysis Software Breakdown Data by Application
    Clinical Diagnoses
    Personal Triage
    Investigational Use
    Based on regional and country-level analysis, the Diabetic Retinopathy (DR) Analysis Software market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa
    In the competitive analysis section of the report, leading as well as prominent players of the global Diabetic Retinopathy (DR) Analysis Software market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The following players are covered in this report:
    Evolucare
    IDx Technologies Inc.
    Yingtong
    Vistel
    MONA
    Eyenuk
    Buy now